Joseph R Pisegna Selected Research

PG 97-269

1/2014

Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph R Pisegna Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 11/2002
6	Obesity 12/2021 - 09/2013
6	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 12/2007 - 06/2002
5	Body Weight (Weight, Body) 01/2021 - 05/2002
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 01/2007
4	Peptic Ulcer (Peptic Ulcers) 08/2017 - 01/2002
3	Fibrosis (Cirrhosis) 12/2021 - 12/2017
3	Hepatitis C 01/2021 - 01/2018
3	Colitis 06/2016 - 01/2014
3	Inflammation (Inflammations) 01/2016 - 05/2012
3	Neoplasm Metastasis (Metastasis) 11/2011 - 02/2006
3	Ulcer 01/2009 - 01/2002
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2020
2	Non-alcoholic Fatty Liver Disease 01/2021 - 10/2019
2	Gastritis 10/2020 - 08/2017
2	Abdominal Pain (Pain, Abdominal) 01/2019 - 10/2003
2	Carcinoid Tumor (Carcinoid) 01/2019 - 11/2011
2	Diarrhea 01/2019 - 10/2003
2	Gastroesophageal Reflux (GERD) 05/2005 - 06/2002
2	Breast Neoplasms (Breast Cancer) 01/2004 - 11/2002
2	Colonic Neoplasms (Colon Cancer) 01/2004 - 11/2002
2	Lung Neoplasms (Lung Cancer) 01/2004 - 11/2002
2	Hemorrhage 10/2003 - 01/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Liver Neoplasms (Liver Cancer) 12/2021
1	Liver Diseases (Liver Disease) 12/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Overweight 10/2020
1	Gastrinoma 10/2020
1	Fatty Liver 10/2019
1	Exanthema (Rash) 01/2019
1	Atrophy 01/2019
1	Fever (Fevers) 01/2019
1	Hypothyroidism 01/2019
1	Type 2 Diabetes Mellitus (MODY) 09/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Chronic Renal Insufficiency 12/2017
1	Infections 12/2017
1	Neuroinflammatory Diseases 10/2017
1	Encephalitis (Encephalitis, Rasmussen) 10/2017
1	Type 2 Hypokalemic Periodic Paralysis 03/2017
1	Deglutition Disorders (Dysphagia) 03/2017
1	Myotonia 03/2017

Drug/Important Bio-Agent (IBA)

7	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 11/2015 - 11/2002
5	AcidsIBA 01/2019 - 02/2006
5	Pantoprazole (Protonix)FDA LinkGeneric 10/2003 - 01/2002
4	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2017
4	Proton Pump InhibitorsIBA 10/2020 - 01/2002
3	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 11/2011
2	LipidsIBA 12/2021 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2020
2	Untranslated RNA (Noncoding RNA)IBA 10/2019 - 01/2016
2	Long Noncoding RNAIBA 10/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Hormones (Hormone)IBA 12/2017 - 11/2002
2	Peptides (Polypeptides)IBA 11/2011 - 07/2006
2	GhrelinIBA 11/2011 - 01/2007
2	Serotonin (5 Hydroxytryptamine)IBA 11/2009 - 07/2006
2	GastrinsIBA 01/2009 - 02/2006
1	Methionine (L-Methionine)FDA Link 01/2022
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	SterolsIBA 12/2021
1	Sterol Regulatory Element Binding ProteinsIBA 12/2021
1	ElementsIBA 12/2021
1	Small Interfering RNA (siRNA)IBA 12/2021
1	Bile Acids and Salts (Bile Acids)IBA 12/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	CholesterolIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	neodymium pyrocatechin disulfonate (NPD)IBA 10/2020
1	Coffee FDA Link 05/2020
1	Dietary ProteinsIBA 05/2020
1	Monounsaturated Fatty AcidsIBA 10/2019
1	EnzymesIBA 10/2019
1	Enhancer RNAsIBA 10/2019
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 10/2019
1	CytokinesIBA 01/2019
1	Secretin FDA Link 01/2019
1	Hemoglobins (Hemoglobin)IBA 09/2018
1	DiureticsIBA 12/2017
1	Glucagon (Glukagon)FDA Link 12/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2017
1	LeptinIBA 12/2017
1	gallium Ga 68 dotatateIBA 11/2017
1	Blood Glucose (Blood Sugar)IBA 10/2017
1	Cholecystokinin (Pancreozymin)IBA 10/2017
1	8-sulfocholecystokinin octapeptideIBA 10/2017
1	AntralIBA 08/2017
1	Voltage-Gated Sodium ChannelsIBA 03/2017

Therapy/Procedure

5	Therapeutics 12/2021 - 06/2002
4	High-Protein Diet 10/2020 - 09/2013
1	Glycemic Control 01/2022
1	Caloric Restriction 01/2021
1	Reducing Diet 10/2020
1	Drug Therapy (Chemotherapy) 01/2018
1	Immunotherapy 01/2018